| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/13543776.2012.649006 |
| P698 | PubMed publication ID | 22191414 |
| P50 | author | Andrea Scozzafava | Q28037168 |
| Claudiu T Supuran | Q28211545 | ||
| Fabrizio Carta | Q56588061 | ||
| P2860 | cites work | The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 |
| Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma | Q27657958 | ||
| Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action | Q27667745 | ||
| Carbonic anhydrase inhibitors | Q28219057 | ||
| Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 | ||
| Carbonic Anhydrase Inhibition/Activation: Trip of a Scientist Around the World in the Search of Novel Chemotypes and Drug Targets | Q37785573 | ||
| Tetrahydroisoquinoline Derivatives As Highly Selective and Potent Rho Kinase Inhibitors | Q38466880 | ||
| Kinin modulation of conventional outflow facility in the bovine eye. | Q42503530 | ||
| Carbonic anhydrase inhibitors | Q43042271 | ||
| Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma | Q43260890 | ||
| Rho-kinase inhibitors: pharmacomodulations on the lead compound Y-32885. | Q44395543 | ||
| Synthesis of novel nitric oxide (NO)-releasing esters of timolol | Q46053441 | ||
| Antiglaucoma Carbonic Anhydrase Inhibitors as Ophthalomologic Drugs | Q58863228 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 79-88 | |
| P577 | publication date | 2011-12-23 | |
| P1433 | published in | Expert Opinion on Therapeutic Patents | Q5421213 |
| P1476 | title | Novel therapies for glaucoma: a patent review 2007 - 2011. | |
| P478 | volume | 22 |
| Q46774097 | 7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits α-carbonic anhydrases without hydrolysis of the lactam ring. |
| Q34631556 | A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects. |
| Q31140231 | A class of carbonic anhydrase I - selective activators. |
| Q38539283 | A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization. |
| Q38543994 | Acetazolamide for the treatment of idiopathic intracranial hypertension |
| Q38991378 | Advances in structure-based drug discovery of carbonic anhydrase inhibitors |
| Q47319716 | Amide derivatives of benzene-sulfonanilide, pharmaceutical composition thereof and method for cancer treatment using the same (US20120095092). |
| Q38089125 | Anti-infective carbonic anhydrase inhibitors: a patent and literature review |
| Q38102786 | Antiglaucoma carbonic anhydrase inhibitors: a patent review |
| Q89618622 | Bioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as carbonic anhydrase inhibitors: synthesis, characterisation and biological evaluation |
| Q38841249 | Carbonic anhydrase inhibition and the management of neuropathic pain |
| Q27676887 | Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in Vivo |
| Q41491551 | Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase. |
| Q38089120 | Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013). |
| Q40115810 | Dorzolamide-induced relaxation of isolated rabbit ciliary arteries mediated by inhibition of extracellular calcium influx |
| Q38733892 | Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors |
| Q38102745 | Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors |
| Q53555670 | Glaucoma-Intraocular Pressure Reduction. |
| Q38653464 | How many carbonic anhydrase inhibition mechanisms exist? |
| Q46800231 | New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: toward a new mode of carbonic anhydrase inhibition by sulfonamides |
| Q38403232 | Nitric oxide donors and selective carbonic anhydrase inhibitors: a dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis. |
| Q38031910 | Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential |
| Q38166844 | Rho kinase inhibitors: a patent review (2012 - 2013). |
| Q42535076 | Seeing is believing: NO therapy for glaucoma? Focus on "Role of nitric oxide in murine conventional outflow physiology". |
| Q37999063 | Structure-based drug discovery of carbonic anhydrase inhibitors |
| Q38235501 | Sulfonamides and their isosters as carbonic anhydrase inhibitors. |
| Q38018632 | Sulfonamides: a patent review (2008 - 2012). |
| Q88417903 | Synthesis and Biological Evaluation of 4-Sulfamoylphenyl/Sulfocoumarin Carboxamides as Selective Inhibitors of Carbonic Anhydrase Isoforms hCA II, IX, and XII |
| Q27321772 | TRPV4 regulates calcium homeostasis, cytoskeletal remodeling, conventional outflow and intraocular pressure in the mammalian eye. |
| Q26765508 | The Endocannabinoid System as a Therapeutic Target in Glaucoma |
| Q64079553 | Thermostability enhancement of the α-carbonic anhydrase from Sulfurihydrogenibium yellowstonense by using the anchoring-and-self-labelling-protein-tag system (ASL) |
| Q27698086 | X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor |
Search more.